Pediatric Rheumatic Diseases (juvenile idiopathic arthritis(JIA), systemic lupus erythematosus(SLE), juvenile dermatomyositis(JDM), Sjogren syndrome(SS),etc)
Conditions
Interventions
None listed
Sponsors
Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The subjects of this study were the patients with pediatric theumatic diseases aged 1 month to 20 years in the acute phase and the recovery phase. The diagnosis of KD was performed according to clinical criteria. The acute phase is defined as the active period before intervention. The recovery phase is defined as the stable period following intervention. We use the samples from the other illnesses aged from 0 to 20 years who were divided into group 1 (G1; viral infection), group 2 (G2; bacterial infection), and group 3 (G3; autoimmune disease beside colagen diseases), and healthy subjects aged 1 month to 20 years served as a control group.
Exclusion criteria
Exclusion criteria: The child who is not obtained the consent by a parent or the person in the groups mentioned above
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find the biomarkers used to establish a new diagnostic method for elucidating pediatric rheumatic diseases' pathogenesis potentially | — |
Countries
Japan
Contacts
Public ContactMasaaki Mori
Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University Department of Lifecourse Clinical Immunology
Outcome results
None listed